Folliculosebaceous cystic hamartoma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Folliculosebaceous cystic hamartoma
File:SkinTumors-P7080424.JPG Folliculosebaceous cystic hamartoma
Synonyms	N/A
Pronounce	N/A
Specialty	Dermatology
Symptoms	Skin lesion, nodule
Complications	N/A
Onset	Middle-aged adults
Duration	Persistent
Types	N/A
Causes	Unknown
Risks	None identified
Diagnosis	Histopathology
Differential diagnosis	Sebaceous adenoma, trichofolliculoma, sebaceous hyperplasia
Prevention	N/A
Treatment	Surgical excision
Medication	N/A
Prognosis	Excellent
Frequency	Rare
Deaths	N/A

Folliculosebaceous Cystic Hamartoma (FSCH) is a rare, benign skin lesion that primarily involves the hair follicles and sebaceous glands. It is considered a type of hamartoma, which is a benign, focal malformation that resembles a neoplasm in the tissue of its origin. FSCH is characterized by its unique histological features, which include a combination of cystic and fibrous components, along with an overgrowth of folliculosebaceous units.

Etiology and Pathogenesis

The exact cause of FSCH remains unclear, but it is thought to arise from a developmental anomaly during embryogenesis. This anomaly leads to the overgrowth of both the follicular and sebaceous components of the skin. Genetic factors may play a role in its development, although specific genetic mutations associated with FSCH have not been identified.

Clinical Presentation

FSCH typically presents as a solitary, slow-growing, skin-colored or yellowish nodule. It is most commonly found on the face, neck, or scalp, but can occur anywhere on the body. The lesion is usually asymptomatic, but can occasionally be tender or pruritic. Due to its benign nature, FSCH does not undergo malignant transformation.

Diagnosis

The diagnosis of FSCH is primarily based on histopathological examination. Key features include a central cystic structure surrounded by an overgrowth of folliculosebaceous units, and a fibrous stroma. Immunohistochemical staining can be used to further characterize the lesion and differentiate it from other similar conditions.

Treatment

Treatment of FSCH is not always necessary, as the condition is benign and usually asymptomatic. However, surgical excision may be performed for cosmetic reasons or if the lesion is symptomatic. Complete excision is curative, and recurrence is rare.

Prognosis

The prognosis for individuals with FSCH is excellent, as it is a benign condition with no potential for malignant transformation. Surgical removal is curative, and recurrence following complete excision is uncommon.

Epidemiology

FSCH is a rare condition, with a limited number of cases reported in the medical literature. It can occur at any age, but most commonly presents in young adults. There is no known gender or racial predilection.